SEC Form D private-offering filing
Nocion Therapeutics, Inc.
A new SEC Form D private-offering notice from Watertown, MA, a $22,999,999 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biopharmaceutical company developing taplucainium, an inhaled treatment for chronic cough, based on charged sodium channel blocker technology licensed from Harvard and Boston Children's Hospital.
Filed 2026-03-13Filed to raise $22,999,999First money in 2025-12-15Raised so far $22,999,999HQ (as filed) Watertown, MASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified nociontx.com↗Named in the filing 10 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.